Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral Neuromodulation
Launched by UNIVERSITY HOSPITAL, LILLE · May 23, 2024
Trial Information
Current as of March 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male of female ≥ 18 years
- • OAB syndrome
- • Indication for a two-staged SNM
- • Under general anaesthesia with Remifentanil and Propofol
- • Patient who has given written consent to participate in the trial
- • Patient willing to comply with all study procedures and duration
- Exclusion Criteria:
- • Tibial neuro-stimulation (last 3 months)
- • Sacral neuromodulation (last 3 months)
- • Botulinum toxin A intra-detrusor injection (last 9 months)
- • Pregnancy in progress
- • Administrative reasons
- • Guardianship/curatorship
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
